Qualified subjects will be enrolled and randomized to either one of the two study groups described above based on their initial modified gingivitis and plaque scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after two weeks, six weeks and three months of product use. All subjects will be followed for adverse events throughout the study
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Modified Gingival Index
Timeframe: baseline, 2 week, 6 week & 3 month
Saxton Bleeding Index
Timeframe: baseline, 2 week, 6 week & 3 month
Modified Quigley-Hein Plaque Index
Timeframe: baseline, 2 week, 6 week & 3 month